2023 Q1 Form 10-K Financial Statement

#000156459023002128 Filed on February 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $12.19M $21.55M $485.4M
YoY Change -96.15% -84.54% 29.38%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $18.91M $15.71M $66.76M
YoY Change 13.63% 6.72% 36.9%
% of Gross Profit
Research & Development $52.65M $28.25M $107.9M
YoY Change 99.68% 64.13% 73.82%
% of Gross Profit
Depreciation & Amortization $2.900M $13.79M $9.000M
YoY Change 107.14% 247.02% 104.55%
% of Gross Profit
Operating Expenses $77.07M $59.32M $268.9M
YoY Change -15.9% 2.67% 333.3%
Operating Profit -$64.87M $216.5M
YoY Change -128.84% 5.92%
Interest Expense $9.759M $12.03M $12.03M
YoY Change 713.25% -537.6% -537.6%
% of Operating Profit 5.56%
Other Income/Expense, Net $16.73M -$5.668M $22.59M
YoY Change 185.48% -195.95% 29.18%
Pretax Income -$48.15M -$31.41M $239.1M
YoY Change -120.86% -137.08% 9.1%
Income Tax -$8.038M -$1.519M $80.58M
% Of Pretax Income 33.7%
Net Earnings -$40.11M -$29.89M $158.5M
YoY Change -123.79% -149.86% 3.29%
Net Earnings / Revenue -328.99% -138.75% 32.66%
Basic Earnings Per Share -$0.14 $0.56
Diluted Earnings Per Share -$0.14 -$0.10 $0.50
COMMON SHARES
Basic Shares Outstanding 287.7M 286.1M 285.1M
Diluted Shares Outstanding 287.8M shares 314.8M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.0M $544.9M $386.5M
YoY Change -64.63% -24.63% -18.82%
Cash & Equivalents $193.0M $44.90M $386.5M
Short-Term Investments $603.5M $500.0M $500.0M
Other Short-Term Assets $99.16M $75.41M $34.06M
YoY Change 242.84% 254.93% 12.45%
Inventory $1.447M $1.532M $1.532M
Prepaid Expenses
Receivables $623.5M $538.5M $538.5M
Other Receivables $79.57M $64.82M $64.82M
Total Short-Term Assets $940.7M $1.025B $1.025B
YoY Change -19.9% 10.29% 10.29%
LONG-TERM ASSETS
Property, Plant & Equipment $233.2M $217.3M $217.3M
YoY Change 91.06% 94.65% 94.65%
Goodwill $47.81M $47.81M
YoY Change 0.0% 0.0%
Intangibles $128.8M $131.5M
YoY Change -11.62% -11.38%
Long-Term Investments $57.58M $72.52M $72.52M
YoY Change -2.21% 44.14% 44.14%
Other Assets $89.85M $46.33M $46.33M
YoY Change 107.07% 51.2% 51.2%
Total Long-Term Assets $557.3M $515.4M $515.4M
YoY Change 33.35% 32.58% 32.58%
TOTAL ASSETS
Total Short-Term Assets $940.7M $1.025B $1.025B
Total Long-Term Assets $557.3M $515.4M $515.4M
Total Assets $1.498B $1.541B $1.541B
YoY Change -5.93% 16.86% 16.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.57M $14.83M $14.83M
YoY Change 69.72% -0.64% -0.64%
Accrued Expenses $5.868M $0.00 $5.583M
YoY Change 52.88%
Deferred Revenue $11.81M $21.61M
YoY Change 28.48% 186.78%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $89.59M $118.3M $118.3M
YoY Change -58.02% -1.95% -1.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.962M $3.086M $156.1M
YoY Change -13.64% 78.07% 15.83%
Total Long-Term Liabilities $199.8M $189.3M $156.1M
YoY Change 16.61% 9.96% 15.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $89.59M $118.3M $118.3M
Total Long-Term Liabilities $199.8M $189.3M $156.1M
Total Liabilities $289.4M $307.6M $307.6M
YoY Change -24.78% 5.05% 5.05%
SHAREHOLDERS EQUITY
Retained Earnings $386.1M $426.2M
YoY Change -11.5% 59.22%
Common Stock $824.4M $808.5M
YoY Change 7.0% 6.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.209B $1.233B $1.233B
YoY Change
Total Liabilities & Shareholders Equity $1.498B $1.541B $1.541B
YoY Change -5.93% 16.86% 16.86%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$40.11M -$29.89M $158.5M
YoY Change -123.79% -149.86% 3.29%
Depreciation, Depletion And Amortization $2.900M $13.79M $9.000M
YoY Change 107.14% 247.02% 104.55%
Cash From Operating Activities -$44.06M $30.91M $277.4M
YoY Change -143.97% -284.97% 13.4%
INVESTING ACTIVITIES
Capital Expenditures $14.98M $12.33M $70.66M
YoY Change 3.37% -230.75% -220.89%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$134.6M -$4.733M -$280.0M
YoY Change 1033.59% -157.15% 2.25%
Cash From Investing Activities -$149.6M -$17.06M -$352.6M
YoY Change 467.32% 1385.03% 6.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$458.0K 349.0K -1.628M
YoY Change -85.37% -80.97% -58.11%
NET CHANGE
Cash From Operating Activities -$44.06M 30.91M 277.4M
Cash From Investing Activities -$149.6M -17.06M -352.6M
Cash From Financing Activities -$458.0K 349.0K -1.628M
Net Change In Cash -$194.3M 14.20M -86.49M
YoY Change -375.61% -188.59% -6.97%
FREE CASH FLOW
Cash From Operating Activities -$44.06M $30.91M $277.4M
Capital Expenditures $14.98M $12.33M $70.66M
Free Cash Flow -$59.05M $18.58M $206.7M
YoY Change -168.88% -355.18% -31.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity File Number
EntityFileNumber
001-39781
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2215 Yukon Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
476142000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386535000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
246835000
CY2021Q4 abcl Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
722977000
CY2021Q4 abcl Accounts And Accrued Receivable Current
AccountsAndAccruedReceivableCurrent
160576000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118918000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10252000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275763745
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285056606
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
263129765
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
318294236
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
314827255
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
36412000
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41848000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29240000
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V5Y 0A1
CY2022 dei City Area Code
CityAreaCode
604
CY2022 dei Local Phone Number
LocalPhoneNumber
559-9005
CY2022 dei Trading Symbol
TradingSymbol
ABCL
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
2404551632000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
287686199
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
189310000
CY2021Q4 us-gaap Liabilities
Liabilities
292836000
CY2022Q4 us-gaap Liabilities
Liabilities
307630000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
283257104
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
283257104
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
286851595
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286851595
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
722430000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
734365000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
35357000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74118000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
280000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1391000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
267666000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
426185000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1025733000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1233277000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1318569000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1540907000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233155000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375203000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
485424000
CY2020 us-gaap Royalty Expense
RoyaltyExpense
27143000
CY2021 us-gaap Royalty Expense
RoyaltyExpense
45516000
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001703057
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#OperatingExpenses
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2022 us-gaap Royalty Expense
RoyaltyExpense
66436000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29393000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62062000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107879000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3842000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6913000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11270000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11910000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55485000
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilities
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilities
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
AbCellera Biologics Inc.
CY2022 dei Security12b Title
Security12bTitle
Common shares, no par value per share
CY2020 abcl Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
4836000
CY2021 abcl Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
14451000
CY2022 abcl Depreciation Amortization And Impairment
DepreciationAmortizationAndImpairment
27843000
CY2020 us-gaap Operating Expenses
OperatingExpenses
77124000
CY2021 us-gaap Operating Expenses
OperatingExpenses
170790000
CY2022 us-gaap Operating Expenses
OperatingExpenses
268913000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
156031000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
204413000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
216511000
CY2022 dei Auditor Firm
AuditorFirmId
85
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
499950000
CY2022Q4 abcl Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
886485000
CY2022Q4 abcl Accounts And Accrued Receivable Current
AccountsAndAccruedReceivableCurrent
38593000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21247000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
75413000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
929800000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1025491000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111616000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217255000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
148392000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
131502000
CY2021Q4 us-gaap Goodwill
Goodwill
47806000
CY2022Q4 us-gaap Goodwill
Goodwill
47806000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
50313000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
72522000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30642000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46331000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
388769000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
515416000
CY2021Q4 us-gaap Assets
Assets
1318569000
CY2022Q4 us-gaap Assets
Assets
1540907000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
32017000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
33150000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
22934000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
44211000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
35683000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
22506000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
19347000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7536000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21612000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
120676000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
118320000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36413000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76675000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
27409000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19516000
CY2021Q4 abcl Deferred Grants Funding Noncurrent
DeferredGrantsFundingNoncurrent
33349000
CY2022Q4 abcl Deferred Grants Funding Noncurrent
DeferredGrantsFundingNoncurrent
40801000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
35886000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
16054000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
37370000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33178000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1733000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3086000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
172160000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
293000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
3330000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
16079000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6811000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6080000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4045000
CY2020 abcl Grants And Incentives
GrantsAndIncentives
8320000
CY2021 abcl Grants And Incentives
GrantsAndIncentives
17486000
CY2022 abcl Grants And Incentives
GrantsAndIncentives
10554000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1802000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14736000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22588000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157833000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
219149000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
239099000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38915000
CY2022 abcl Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
1066000
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-350000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-778000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65685000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80580000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
153464000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
158519000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
280000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1671000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
118918000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
153744000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
156848000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159195023
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
74662000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
942000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4127000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118918000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
830508000
CY2021 abcl Stock Issued During Period Value Stock Options And Other
StockIssuedDuringPeriodValueStockOptionsAndOther
6566000
CY2021 abcl Adjustments To Additional Paid In Capital Reclassification Of Liability Classified Options
AdjustmentsToAdditionalPaidInCapitalReclassificationOfLiabilityClassifiedOptions
5675000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
280000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
153464000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1025733000
CY2022 abcl Stock Issued And Restricted Stock Units Vested During Period Value Stock Options Exercised
StockIssuedAndRestrictedStockUnitsVestedDuringPeriodValueStockOptionsExercised
1215000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49481000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1671000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
158519000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1233277000
CY2020 us-gaap Profit Loss
ProfitLoss
118918000
CY2021 us-gaap Profit Loss
ProfitLoss
153464000
CY2022 us-gaap Profit Loss
ProfitLoss
158519000
CY2020 us-gaap Depreciation
Depreciation
2317000
CY2021 us-gaap Depreciation
Depreciation
4403000
CY2022 us-gaap Depreciation
Depreciation
8953000
CY2020 abcl Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
2519000
CY2021 abcl Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
10062000
CY2022 abcl Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
18890000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
435000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2785000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5259000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
8397000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
30646000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
49481000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2098000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2018000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2114000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4707000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3570000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8547000
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5467000
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
37386000
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
22715000
CY2020 abcl Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
197553000
CY2021 abcl Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
-59864000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3064000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
21810000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8624000
CY2022 abcl Increase Decrease In Accrued Royalties Receivable
IncreaseDecreaseInAccruedRoyaltiesReceivable
-129171000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-13530000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-88609000
CY2020 abcl Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
6601000
CY2021 abcl Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Royalties Payable
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesExcludingRoyaltiesPayable
1400000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
501142000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
594116000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
501142000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6183000
CY2020 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
27143000
CY2021 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-4637000
CY2022 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-3160000
CY2020 abcl Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
6763000
CY2021 abcl Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
-30718000
CY2022 abcl Increase Decrease In Deferred Grant Income
IncreaseDecreaseInDeferredGrantIncome
-9264000
CY2020 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1466000
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2603000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1689000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22690000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
244584000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
277360000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9673000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58452000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70660000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5000000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
274710000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
763982000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27608000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
510631000
CY2021 abcl Proceeds From Receipt Of Grant Funding
ProceedsFromReceiptOfGrantFunding
32621000
CY2022 abcl Proceeds From Receipt Of Grant Funding
ProceedsFromReceiptOfGrantFunding
16434000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
87643000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11457000
CY2020 abcl Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
-1783000
CY2021 abcl Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
17534000
CY2022 abcl Payments To Acquire Long Term Investments And Other Assets
PaymentsToAcquireLongTermInvestmentsAndOtherAssets
17369000
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
19247000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
30323000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25679000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-119780000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-332247000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-352625000
CY2020 abcl Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
19942000
CY2021 abcl Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
4373000
CY2022 abcl Repayment Of Long Term Debt And Contingent Consideration
RepaymentOfLongTermDebtAndContingentConsideration
323000
CY2020 abcl Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
16490000
CY2021 abcl Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
5487000
CY2022 abcl Proceeds From Debt And Exercise Of Stock Options
ProceedsFromDebtAndExerciseOfStockOptions
2755000
CY2020 abcl Proceeds From Convertible Debentures
ProceedsFromConvertibleDebentures
89990000
CY2020 abcl Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
387000
CY2021 abcl Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
5000000
CY2022 abcl Payment Of Liability For In Licensing Agreement And Other
PaymentOfLiabilityForInLicensingAgreementAndOther
4060000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
522840000
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
74662000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
683653000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3886000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1628000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1425000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9599000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
586563000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92974000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-86492000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
414650000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3115000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7553000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
594116000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
594116000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
501142000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411535000
CY2020 abcl Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
656000
CY2021 abcl Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
5397000
CY2022 abcl Non Cash Or Part Non Cash Acquisition Property And Equipment Purchases In Accounts Payable
NonCashOrPartNonCashAcquisitionPropertyAndEquipmentPurchasesInAccountsPayable
5868000
CY2020 abcl Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
1679000
CY2021 abcl Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
36638000
CY2022 abcl Noncash Or Part Noncash Acquisition Right Of Use Assets Obtained In Exchange For Operating Lease Obligation
NoncashOrPartNoncashAcquisitionRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligation
50694000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
9060000
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">1. Nature of operations</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.4%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AbCellera Biologics Inc.’s (the “Company”) mission is to bring better antibody drugs to patients faster, solve long-standing problems, and transform how antibody drugs are discovered. The Company aims to bring antibody therapeutics from target to clinic by combining expertise, technologies, and infrastructure to build an engine for antibody drug discovery and development. The Company <span style="color:#000000;">uses the engine to work with partners to build a large and diversified portfolio of royalty (and equivalent) stakes in future antibody drugs</span>. The Company partners with companies of all sizes - from innovative biotechnology companies to leading pharmaceutical companies - propelling programs to the clinic, together.</p>
CY2020Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1-for-10
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2022Q4 abcl Company Contributed Segregated Account Representing Loss
CompanyContributedSegregatedAccountRepresentingLoss
25000000.0
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:1.69%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:3.4%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Areas of significant estimates include, but are not limited to, revenue recognition including estimated timing of completion of performance obligations and </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">determining whether an option for additional goods or services represents a material right, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the fair</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> value of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">acquired intangible assets, and </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">contingent consideration payable</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of stock-based compensation awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">facts</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and experience. Changes in estimates are recorded in the period in which they become known. Actual results could significantly differ from those estimates. </span></p>
CY2021Q4 us-gaap Cash
Cash
100500000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
375600000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
25000000.0
CY2022Q4 us-gaap Cash
Cash
126200000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
260300000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
28100000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000000.0
CY2022Q4 abcl Restricted Cash Current Other Current Assets
RestrictedCashCurrentOtherCurrentAssets
2200000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
900000
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
500000
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
7007000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.50
CY2022Q4 abcl Deferred Compensation Share Based Arrangements Liability Classified Noncurrent Outstanding
DeferredCompensationShareBasedArrangementsLiabilityClassifiedNoncurrentOutstanding
0
CY2021Q4 abcl Deferred Compensation Share Based Arrangements Liability Classified Noncurrent Outstanding
DeferredCompensationShareBasedArrangementsLiabilityClassifiedNoncurrentOutstanding
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
11710000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118918000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
153464000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
158519000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
33817000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
85101000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
153464000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
158519000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159195023
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275763745
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285056606
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
118918000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
153464000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
158519000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159195023
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
275763745
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
285056606
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
63260090
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
40674652
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
42530491
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
29770649
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
263129765
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
318294236
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
314827255
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
908409
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11824006
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-680000
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14282000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
64817000
CY2021Q4 abcl Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
5293000
CY2022Q4 abcl Prepaid Expense And Other Current
PrepaidExpenseAndOtherCurrent
9064000
CY2021Q4 abcl Materials And Supplies Current
MaterialsAndSuppliesCurrent
1672000
CY2022Q4 abcl Materials And Supplies Current
MaterialsAndSuppliesCurrent
1532000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21247000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
75413000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
121442000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
235730000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9826000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18475000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111616000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
217255000
CY2021Q4 abcl Building And Leasehold Improvements Include Construction And Tenant Improvements Gross
BuildingAndLeaseholdImprovementsIncludeConstructionAndTenantImprovementsGross
19800000
CY2022Q4 abcl Building And Leasehold Improvements Include Construction And Tenant Improvements Gross
BuildingAndLeaseholdImprovementsIncludeConstructionAndTenantImprovementsGross
25600000
CY2020 us-gaap Depreciation
Depreciation
2300000
CY2021 us-gaap Depreciation
Depreciation
4400000
CY2022 us-gaap Depreciation
Depreciation
9000000.0
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
160973000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12581000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
148392000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
154583000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23081000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
131502000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10100000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10500000
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
8400000
CY2022 abcl Impairment Of Intangible Assets Finite Lived Net Of Deferred Income Tax
ImpairmentOfIntangibleAssetsFiniteLivedNetOfDeferredIncomeTax
6300000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5007000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8318000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10625000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5810000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4241000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4241000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4241000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29158000
CY2020Q4 us-gaap Goodwill
Goodwill
31500000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16306000
CY2021Q4 us-gaap Goodwill
Goodwill
47806000
CY2022Q4 us-gaap Goodwill
Goodwill
47806000
CY2022 abcl Number Of Joint Ventures
NumberOfJointVentures
2
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14924000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14828000
CY2021Q4 abcl Liability For In Licensing Agreement Current
LiabilityForInLicensingAgreementCurrent
4933000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3652000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5583000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4035000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6454000
CY2021Q4 abcl Deferred Grant Funding Current
DeferredGrantFundingCurrent
4473000
CY2022Q4 abcl Deferred Grant Funding Current
DeferredGrantFundingCurrent
6285000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
32017000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
33150000
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
283257104
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
283257104
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
286851595
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286851595
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each voting common share entitles the holder to one vote on all matters submitted to a vote of the Company’s shareholders.
CY2022 us-gaap Dividends Cash
DividendsCash
0
CY2021Q1 abcl Conversion Of Liability Classified Options To Equity
ConversionOfLiabilityClassifiedOptionsToEquity
5700000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8397000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30646000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49481000
CY2022 us-gaap Dividends
Dividends
0
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34954000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41128000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000.0
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4700000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11500000
CY2020 abcl Received Funding Commitment
ReceivedFundingCommitment
175600000
CY2022 abcl Received Funding Commitment
ReceivedFundingCommitment
129700000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0
CY2020 abcl Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
12400000
CY2021 abcl Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
47100000
CY2022 abcl Strategic Innovation Fund Eligible Expenditure
StrategicInnovationFundEligibleExpenditure
18900000
CY2020 abcl Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
5300000
CY2021 abcl Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
13800000
CY2022 abcl Research And Development Eligible Expenditure
ResearchAndDevelopmentEligibleExpenditure
3900000
CY2022 abcl Capital Expenditures Incurred And Paid
CapitalExpendituresIncurredAndPaid
15000000.0
CY2022 abcl Capital Asset Expenditures Amortize Over Average Asset Life Period
CapitalAssetExpendituresAmortizeOverAverageAssetLifePeriod
P7Y
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
163077000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
211471000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
279771000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5244000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
7678000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-40672000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157833000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
219149000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
239099000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
36931000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
60498000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81392000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-114000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
7248000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1300000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
36817000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
67746000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
82692000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2461000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1342000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2322000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-363000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-719000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-4434000
CY2020 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
2098000
CY2021 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
-2061000
CY2022 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
-2112000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38915000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65685000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80580000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
36817000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
67746000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
82692000
CY2020 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
2098000
CY2021 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
-2061000
CY2022 abcl Deferred And Other Income Tax Expense Benefit
DeferredAndOtherIncomeTaxExpenseBenefit
-2112000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38915000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65685000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80580000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
157833000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
219149000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
239099000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.27
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
42615000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
59170000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
64557000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1934000
CY2022 abcl Income Tax Reconciliation Change In Tax Rate Differential
IncomeTaxReconciliationChangeInTaxRateDifferential
1911000
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
36000
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
1000
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
3529000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1698000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4809000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
5908000
CY2020 abcl Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
-4048000
CY2021 abcl Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
47000
CY2022 abcl Effective Income Tax Rate Reconciliation At Foreign Exchange
EffectiveIncomeTaxRateReconciliationAtForeignExchange
536000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
756000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-738000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-251000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38915000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65685000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80580000
CY2021Q4 abcl Deferred Tax Assets Long Term Debt
DeferredTaxAssetsLongTermDebt
6293000
CY2022Q4 abcl Deferred Tax Assets Long Term Debt
DeferredTaxAssetsLongTermDebt
7695000
CY2021Q4 abcl Deferred Tax Assets Financing Fee
DeferredTaxAssetsFinancingFee
6575000
CY2022Q4 abcl Deferred Tax Assets Financing Fee
DeferredTaxAssetsFinancingFee
4827000
CY2021Q4 abcl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
5299000
CY2022Q4 abcl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
17355000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4768000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
6042000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4996000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5054000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1807000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3019000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4696000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30950000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47476000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3256000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
6443000
CY2021Q4 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
2135000
CY2022Q4 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
2007000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
36866000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
32682000
CY2021Q4 abcl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
4732000
CY2022Q4 abcl Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
16687000
CY2021Q4 abcl Deferred Tax Liabilities Government Funding Receivable
DeferredTaxLiabilitiesGovernmentFundingReceivable
3029000
CY2022Q4 abcl Deferred Tax Liabilities Government Funding Receivable
DeferredTaxLiabilitiesGovernmentFundingReceivable
1657000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1661000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2437000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
51679000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
61913000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20729000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14437000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9233000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13411000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
29962000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
27848000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
21717000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
34065000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
51679000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
61913000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
29962000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
27848000
CY2021Q4 abcl Deferred Tax Assets Other Long Term Assets
DeferredTaxAssetsOtherLongTermAssets
7400000
CY2022Q4 abcl Deferred Tax Assets Other Long Term Assets
DeferredTaxAssetsOtherLongTermAssets
5300000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
37400000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33200000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9200000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13400000
CY2022Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
7200000
CY2022 abcl Non Capital Loss And Investment Tax Credits Backup Period
NonCapitalLossAndInvestmentTaxCreditsBackupPeriod
P3Y
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1500000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
18200000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
19400000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
387000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
109000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
109000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
387000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
109000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
109000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3652000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5583000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
36413000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76675000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
40065000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
82258000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9610000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9242000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9132000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8872000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8857000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
65912000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3700000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
7100000
CY2020 us-gaap Variable Lease Payment
VariableLeasePayment
300000
CY2021 us-gaap Variable Lease Payment
VariableLeasePayment
400000
CY2022 us-gaap Variable Lease Payment
VariableLeasePayment
1800000
CY2020 us-gaap Royalty Expense
RoyaltyExpense
27100000
CY2021 us-gaap Royalty Expense
RoyaltyExpense
45500000
CY2022 us-gaap Royalty Expense
RoyaltyExpense
66400000
CY2021Q4 abcl Accounts And Accrued Royalty Receivable Amounts Due Number Of Customers
AccountsAndAccruedRoyaltyReceivableAmountsDueNumberOfCustomers
13
CY2022Q4 abcl Accounts And Accrued Royalty Receivable Amounts Due Number Of Customers
AccountsAndAccruedRoyaltyReceivableAmountsDueNumberOfCustomers
21
CY2021 abcl Recognized Milestone Payments
RecognizedMilestonePayments
7000000.0
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386500000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
28100000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
500000000.0
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0100
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8200000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44900000
CY2022Q4 abcl Business Acquisitions Purchase Price Allocation Adjustments
BusinessAcquisitionsPurchasePriceAllocationAdjustments
0

Files In Submission

Name View Source Status
0001564590-23-002128-index-headers.html Edgar Link pending
0001564590-23-002128-index.html Edgar Link pending
0001564590-23-002128.txt Edgar Link pending
0001564590-23-002128-xbrl.zip Edgar Link pending
abcl-10k_20221231.htm Edgar Link pending
abcl-20221231.xsd Edgar Link pending
abcl-ex211_511.htm Edgar Link pending
abcl-ex231_185.htm Edgar Link pending
abcl-ex311_183.htm Edgar Link pending
abcl-ex312_184.htm Edgar Link pending
abcl-ex321_182.htm Edgar Link pending
abcl-ex322_181.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gafprv2jfx2e000001.jpg Edgar Link pending
gafprv2jfx2e000002.jpg Edgar Link pending
gafprv2jfx2e000003.jpg Edgar Link pending
gafprv2jfx2e000004.jpg Edgar Link pending
gafprv2jfx2e000005.jpg Edgar Link pending
gafprv2jfx2e000006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
abcl-20221231_cal.xml Edgar Link unprocessable
abcl-20221231_def.xml Edgar Link unprocessable
abcl-20221231_lab.xml Edgar Link unprocessable
abcl-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
abcl-10k_20221231_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending